Revance Therapeutics Inc. said it appointed Tobin Schilke as the company's CFO, effective Nov. 5.

Schilke has been serving as the CFO of Achaogen Inc. since 2016.

Prior to Achaogen, Schilke spent 13 years at Roche Holding AG and its subsidiary Genentech Inc. in a variety of senior finance and operational roles.

Newark, Calif.-based Revance Therapeutics is developing a generic version of Allergan PLC's Botox.